| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01XJ02 |
| UNII: | 0RLU3VTK5M |
| InChI Key | VZZJRYRQSPEMTK-CALCHBBNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H26F3N3O3 |
| Molecular Weight | 485.51 |
| AlogP | 5.82 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 63.69 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 35.0 |
| Primary Target | |
|---|---|
| SMO |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Frizzled family G protein-coupled receptor
Smoothened receptor (frizzled family GPCR)
|
- | - | - | 6 | - | |
|
Unclassified protein
|
- | 6 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Medulloblastoma | 2 | D008527 | ClinicalTrials |
| Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
| Esophageal Neoplasms | 1 | D004938 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 956697-53-3 |
| ChEBI | 90863 |
| ChEMBL | CHEMBL2105737 |
| DrugBank | DB09143 |
| DrugCentral | 5008 |
| FDA SRS | 0RLU3VTK5M |
| Guide to Pharmacology | 8199 |
| PubChem | 24775005 |
| SureChEMBL | SCHEMBL554455 |
| ZINC | ZINC000068202099 |